APPLICATION
BLA017835
TYPE
BLA
ORIGINAL APPROVAL
1976-02-23
LATEST ACTION
1986-07-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CHROMALBINDiscontinued
ALBUMIN CHROMATED CR-51 SERUM 250uCi/VIAL · INJECTABLE · INJECTION
CHROMALBINDiscontinued
ALBUMIN CHROMATED CR-51 SERUM 500uCi/VIAL · INJECTABLE · INJECTION
CHROMALBINDiscontinued
ALBUMIN CHROMATED CR-51 SERUM 100uCi/VIAL · INJECTABLE · INJECTION
Approval history
1986-07-17Manufacturing (CMC) · Supplement 8 · priorityAP
1981-07-29Manufacturing (CMC) · Supplement 7 · priorityAP
1979-03-08Labeling · Supplement 5AP
1979-03-08Labeling · Supplement 6AP
1978-02-28Labeling · Supplement 2AP
1978-02-28Labeling · Supplement 4AP
1976-07-16Manufacturing (CMC) · Supplement 1 · priorityAP
1976-02-23Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.